跳至主要内容
临床试验/IRCT20210730052022N1
IRCT20210730052022N1招募中未知

Assessment of serum levels of Beta hydroxybutyrate, Glucagon, Cortisol and Insulin before and after one month treatment with Empagliflozin in comparison with Metformin in type 2 diabetic patients

Shiraz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 no limit(—)
性别
All

入选标准

  • Type 2 diabetic patients
  • Thirty year old or more
  • Uncontrolled blood sugar after at least 3 months treatment with Metformin

排除标准

  • Pregnant and lactating women
  • Renal failure (Glomerular Filtration Rate (GFR) less than 45 milliliters per minute)
  • Previous history of diabetic ketoacidosis (DKA)
  • Previous history of amputation due to diabetes
  • Consumption of drugs that affect the parameters of study

研究者

相似试验